Celularity (CELU) News Today $2.26 +0.15 (+7.11%) Closing price 09/9/2025 04:00 PM EasternExtended Trading$2.47 +0.21 (+9.42%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELU Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period WBB Securities Upgrades Celularity (CELU)5 hours ago | msn.comCelularity (NASDAQ:CELU) Upgraded to Buy at WBB SecuritiesSeptember 10 at 2:17 AM | americanbankingnews.comCelularity (NASDAQ:CELU) Cut to "Sell" at Wall Street ZenSeptember 8 at 2:49 AM | americanbankingnews.comCelularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) ComplianceSeptember 3, 2025 | globenewswire.comCelularity Second Quarter 2025 Earnings: US$1.02 loss per share (vs US$0.30 loss in 2Q 2024)August 31, 2025 | finance.yahoo.comCelularity (NASDAQ:CELU) Trading 1.3% Higher After Analyst UpgradeAugust 27, 2025 | marketbeat.comCelularity receives noncompliance notice from NasdaqAugust 22, 2025 | msn.comCelularity Receives Nasdaq Notice Regarding Form 10-QAugust 22, 2025 | globenewswire.comWBB Securities Begins Coverage on Celularity (NASDAQ:CELU)August 20, 2025 | marketbeat.comWBB Securities Initiates Coverage of Celularity (CELU) with Speculative Buy RecommendationAugust 19, 2025 | msn.comBRIEF-Celularity Completes Major Balance Sheet RestructuringAugust 18, 2025 | sg.finance.yahoo.comCelularity completes balance sheet restructuring, retires $41.6M in debtAugust 18, 2025 | msn.comCelularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured DebtAugust 18, 2025 | globenewswire.comCelularity Enters Series Seed Stock Agreement with DefeyeAugust 12, 2025 | msn.comWall Street Zen Upgrades Celularity (NASDAQ:CELU) to "Sell"August 3, 2025 | marketbeat.comCelularity (NASDAQ:CELU) Shares Down 3% - Time to Sell?July 30, 2025 | marketbeat.comCelularity Inc. (CELU) Stock Price Today - WSJJuly 24, 2025 | wsj.comCelularity Inc. Partners with Fountain Life to Provide Stem Cell ...July 10, 2025 | nasdaq.comCelularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida LawJuly 9, 2025 | globenewswire.comCelularity Inc. Supports New Florida Law Authorizing Stem Cell Therapies for Physicians - NasdaqJuly 3, 2025 | nasdaq.comCelularity Hails New Florida Law Opening Patient Access to Stem Cell TherapiesJuly 1, 2025 | globenewswire.com# Celularity terminates CFO, appoints interim replacementJune 11, 2025 | investing.comCelularity Inc. Announces Termination of CFO David Beers, Appoints Joseph DosSantos as Interim CFOJune 11, 2025 | nasdaq.comCelularity stock falls after CFO David Beers terminatedJune 10, 2025 | au.investing.comCelularity Terminates CFO David BeersJune 10, 2025 | marketwatch.comCelularity Announces Chief Financial Officer TransitionJune 10, 2025 | globenewswire.comCelularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane TechnologyJune 2, 2025 | globenewswire.comCELUW Celularity Inc. WT EXP 071626June 1, 2025 | seekingalpha.comCelularity Inc.: Celularity Receives Nasdaq Notice Regarding Form 10-QMay 31, 2025 | finanznachrichten.deCelularity Receives Nasdaq Notice Regarding Form 10-QMay 30, 2025 | globenewswire.comCelularity (NASDAQ:CELU) Stock Rating Lowered by Wall Street ZenMay 24, 2025 | marketbeat.comCelularity (NASDAQ:CELU) Trading 7.4% Higher - Here's WhyMay 23, 2025 | marketbeat.comCelularity extiende vencimiento de deuda y emite acciones a YA II PNMay 22, 2025 | es.investing.comCelularity extends debt maturity, issues stock to YA II PNMay 22, 2025 | uk.investing.comCelularity Extends Note Maturity with YA II PNMay 20, 2025 | tipranks.comCelularity Inc.: Celularity Announces Full Year 2024 Operating and Financial ResultsMay 9, 2025 | finanznachrichten.deCelularity Inc. Reports Strong Financial Growth and Increased Revenue for Year Ended December 31, 2024May 9, 2025 | quiverquant.comQCelularity Announces Full Year 2024 Operating and Financial ResultsMay 9, 2025 | globenewswire.comCelularity receives notice regarding non-payment of Nasdaq feesApril 26, 2025 | markets.businessinsider.comCelularity pays $70,000 fee to Nasdaq following receipt of noticeApril 26, 2025 | msn.comCelularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq FeesApril 25, 2025 | globenewswire.comCelularity welcomes CMS action on Medicare LCD for skin substitutes productsApril 14, 2025 | markets.businessinsider.comCelularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes ProductsApril 14, 2025 | globenewswire.comCelularity announces publication highlighting potential of CYNK-001April 9, 2025 | markets.businessinsider.comCelularity extiende vencimiento de deuda y emite acciones a inversionistaMarch 23, 2025 | es.investing.comCelularity extends debt maturity, issues stock to investorMarch 23, 2025 | uk.investing.comCelularity receives FDA TRG recommendation letters for Natalin, AcelagraftFebruary 25, 2025 | msn.comCelularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care ProductsFebruary 25, 2025 | markets.businessinsider.comCelularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care ProductsFebruary 25, 2025 | globenewswire.comCelularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy CompanyFebruary 24, 2025 | globenewswire.com Get Celularity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELU and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CELU Media Mentions By Week CELU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CELU News Sentiment▼0.500.81▲Average Medical News Sentiment CELU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CELU Articles This Week▼31▲CELU Articles Average Week Get the Latest News and Ratings for CELU and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Celularity and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AQST News Today OLMA News Today RCKT News Today FULC News Today ABEO News Today ALDX News Today ATXS News Today BNTC News Today ADCT News Today IMAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CELU) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celularity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celularity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
